Exenatide and the treatment of patients with Parkinsons disease
Upon effectiveness of the Novo Collaboration Agreement on July 1, 2025, the Company and Novo have commenced four simultaneous research and development programs (each an R&D Program), each pursuing one or more Collaboration Targets (as defined in the Novo Collaboration Agreement) from discovery through development candidate selection
It is often used for children with attention deficit hyperactivity disorder (ADHD) or delayed sleep wake phase disorder (DSWPD) and for the short-term treatment of insomnia
The lowest Phase 2 obesity arm was 1 mg weekly and produced 8.7% weight loss at 48 weeks, but the calculator starts below the trial dose to create a slower adaptation ladder
Lang CN, Menza M, Jochem S, Franke G, Perez Feliz S, Brunner M, Koren G, Zehender M, Bugger H, Jung BA, Foell D, Bode C, Odening KE (2016) Electro-mechanical dysfunction in long QT syndrome: role for arrhythmogenic risk prediction and modulation by sex and sex hormones
, (BRCA1, ATM), (COL1A1, COL3A1, ELN) (SOD1, SOD2, GPX)